Houston, Texas 77030


Atherosclerosis is a disease in which the blood vessels become blocked by plaques (consisting of fat, calcification, and fibrous tissue), reducing blood flow to vital organs and tissues.Blockage of the carotid arteries in the neck is a major cause of stroke. One way of treating carotid atherosclerosis is with cholesterol-lowering drugs called statins. Statins have been shown to reduce the risk of coronary heart disease by 24-40% and risk pf stroke by 11-30%.The purpose of this study is to determine if short term treatment with atorvastatin causes early favorable changes in the plaques that block blood flow through the carotid arteries. These changes can be assessed 1) by taking pictures of the carotid arteries with MRI and Ultrasound before and after statin treatment, and 2) by special studies of the plaques removed from the carotid arteries by surgery.

Study summary:

Candidates for bilateral carotid endarterectomy (CEA) who meet study criteria will provide informed consent before their randomization. Before the first CEA, the patient will have MRI, US, and EBCT exams of both carotids. The most occlusive plaque will be resected at the first CEA. The patient will then receive atorvastatin 80 mg/day for 3 months. Then the second CEA will be performed. Six weeks after the second CEA, the patient will have another MRI, US, and EBCT exam and at 6, 12, and 18 months thereafter. This protocol will allow comparison of the characteristics of the plaque that has been exposed to drug vs the plaque that has not been exposed. It will also allow monitoring the effect of drug on restenosis after surgery.


Inclusion Criteria: - Men or women - >18 yrs old - Expected to have an endarterectomy on each carotid artery - No contraindications for atorvastatin - Stable cardiovascular health - Lipid lowering treatment less than 6 mo duration - Diabetic included if diabetes is controlled - Patient is not claustrophobic - Patient has evaluable carotid plaques. Exclusion Criteria: - Patient has had previous carotid endarterectomy,stenting, or other procedure - Unstable cardiovascular status - Hypersensitivity to statin therapy - Neck anatomy preventing acquiring bilateral evaluable plaques - Weight over 285 lbs.



Primary Contact:

Principal Investigator
Joel D Morrisett, PhD
Baylor College of Medicine

William Insull, M.D.
Phone: 713-798-4128
Email: winsull@bcm.tmc.edu

Backup Contact:

Email: ataylor@bcm.tmc.edu
Addison Taylor, MD/PhD
Phone: 713-798-4721

Location Contact:

Houston, Texas 77030
United States

Joel D Morrisett, PhD
Phone: 713-798-4164
Email: morriset@bcm.tmc.edu

Site Status: Recruiting

Data Source: ClinicalTrials.gov

Date Processed: March 16, 2018

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.

Click to view Full Listing

If you would like to be contacted by the clinical trial representative please fill out the form below.